| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |